Glimepiride 1mg Metformin 500mg

₹ 80/Strip

Pack TypeBox
Pack Size10*10 Tablets
ManufacturerHEILEN LIFE PHARMACEUTICAL
BrandGLIMHEIL M1
Usage / ApplicationType 2 diabetes
Shelf Life2 years
UsageTo Treat Type 2 Diabetes
Prescription / Non PrescriptionPrescription
Also givesPCD Pharma Franchise
AvailabilityIn Stock
Glimepiride+Metformin Hydrochloride 1mg/500mg Tablet PR is a combination of two medicines: Glimepiride and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus. It improves blood glucose levels in adults when taken along with proper diet and regular exercise.

More Products from Heilen Life Pharmaceutical

Find products similar to Glimepiride 1mg Metformin 500mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Glimepiride 1mg Metformin 500mg image 1Glimepiride 1mg Metformin 500mg image 2Glimepiride 1mg Metformin 500mg image 3Glimepiride 1mg Metformin 500mg image 4Glimepiride 1mg Metformin 500mg image 5Glimepiride 1mg Metformin 500mg image 6Glimepiride 1mg Metformin 500mg image 7

About the Company

GST Registration Year
2022
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Oct 2022
GST
06**********1Z1

Established in the year of 2022, We “ Heilen Life Pharmaceutical ” are” Wholesale Trader And Service Provider ” of an “ PCD Pharma Franchise In India, Allopathic PCDPharma Franchise, Pharma PCD Franchise, Pharmaceutical Capsules, Diclofenac Potassium Tablets etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our “Mr. Ashish Gupta.” whose continual backing and direction have been useful to us for attaining exponential development in the current market.